Archives
FITC Goat Anti-Mouse IgG (H+L) Antibody Guide
FITC Goat Anti-Mouse IgG (H+L) Antibody: Practical Use Guide
The FITC Goat Anti-Mouse IgG (H+L) Antibody (SKU K1201) is an affinity-purified polyclonal secondary antibody for fluorescent detection of mouse IgG. It is supplied as a liquid at 1 mg/mL in PBS containing glycerol, BSA, and sodium azide. The guidance below separates supplied product specifications from workflow recommendations; no directly matched paper evidence is available here to support model-specific performance claims. See the FITC Goat Anti-Mouse IgG (H+L) Antibody product information from APExBIO for the product details.
What This Product Solves
In an indirect fluorescence assay, the primary antibody provides target recognition and the labeled secondary provides the fluorescent readout. K1201 is intended for workflows in which the primary antibody is a mouse IgG and researchers need to detect its bound fraction using FITC fluorescence. The goat polyclonal antibody was generated against pooled mouse IgG and purified by immunoaffinity chromatography. The dossier describes high specificity and minimal cross-reactivity, but researchers should still test background in their own sample type and staining conditions.
Because more than one secondary antibody can bind a primary antibody molecule, this format can support signal amplification in immunoassays. That increased signal is useful for visualization, but it does not establish target specificity by itself: interpretation still depends on primary-antibody validation, controls, and appropriate imaging or cytometry settings. K1201 is described for immunofluorescence, fluorescence microscopy, and flow cytometry. It is a fluorescein-conjugated secondary antibody, so FITC excitation and emission compatibility, autofluorescence, and photobleaching should be considered before selecting it.
Protocol Parameters
- Assay: Immunofluorescence. Parameter: Supplied stock concentration is 1 mg/mL; a working dilution is not specified in the product dossier. Applicability: Detection of a bound mouse IgG primary antibody in fixed or otherwise appropriately prepared samples. Rationale: Establish a dilution series in the actual sample and imaging setup rather than assuming a universal working concentration. This is a workflow recommendation; the stock concentration is a product specification.
- Assay: Flow cytometry. Parameter: Supplied stock concentration is 1 mg/mL; determine the working concentration by titration. Applicability: Fluorescent labeling of cells stained with a compatible mouse IgG primary antibody. Rationale: Titration helps balance specific signal against nonspecific staining in the relevant cell type and panel. The stock concentration is a product specification; titration is a workflow recommendation.
- Assay: Short-term handling and storage. Parameter: Store at 4°C for up to 2 weeks. Applicability: Product held for near-term use. Rationale: Follow the stated handling window and protect the fluorescent conjugate from light. These values are product dossier specifications.
- Assay: Longer-term storage. Parameter: Aliquot and store at -20°C for up to 12 months; avoid repeated freeze-thaw cycles. Applicability: Product not expected to be used within the short-term storage period. Rationale: Aliquoting limits repeated temperature cycling; minimize light exposure during handling. These values are product dossier specifications.
Workflow Setup and QC Checklist
- Confirm antibody compatibility. Verify that the primary antibody is a mouse IgG and that the assay is designed for indirect detection. Check the primary antibody’s host species, isotype information, and target-validation data; do not assume K1201 will detect a primary raised in another species.
- Plan controls before staining. Include a sample without primary antibody to assess secondary-only background, and a relevant unstained or fluorescence control to identify sample autofluorescence. Where practical, compare the complete staining condition with the matched negative control. In flow cytometry, include controls appropriate for the panel and compensation strategy.
- Titrate the secondary. Keep the primary-antibody conditions fixed while testing a range of K1201 working dilutions. Select a condition that separates the expected positive population or structure from background without saturating the detector. The dossier gives a stock concentration but does not specify an application dilution or incubation time.
- Protect the fluorophore. Limit unnecessary light exposure during dilution, staining, and acquisition. For microscopy, use settings that avoid detector saturation and acquire comparable samples with consistent exposure or detector settings. For flow cytometry, confirm that the instrument configuration can resolve the FITC signal and that other panel fluorophores do not create unacceptable overlap.
- Prepare samples appropriately. For intracellular targets, fixation and permeabilization may be required; select these steps according to the target and primary-antibody protocol. For cell-surface flow staining, use a validated cell preparation and consider whether Fc-receptor blocking is appropriate for the sample. These are assay-dependent workflow choices, not product-specific instructions.
- Check the formulation and handling. The supplied liquid contains 23% glycerol, 1% BSA, and 0.02% sodium azide in PBS. Mix gently and avoid contamination when withdrawing aliquots. The preservative and carrier can matter for specialized downstream steps, so assess compatibility with the full assay rather than assuming the reagent is suitable for every live-cell or enzyme-based workflow.
The internal article FITC Goat Anti-Mouse IgG (H+L) Antibody: Technical Use Guide provides related application context for immunofluorescence and flow cytometry. The article FITC Goat Anti-Mouse IgG: Assay Logic is relevant for distinguishing fluorescence signal amplification from evidence of biological mechanism.
Common Failure Modes and Fixes
- High background across the sample: Check secondary-only controls, reduce the working concentration through titration, and review blocking and washing steps. Confirm that the secondary is compatible with the primary-antibody host and sample preparation.
- Weak or absent fluorescence: Verify primary-antibody binding and the staining sequence first. Confirm that the instrument is configured for FITC, that the conjugate has been stored within the stated conditions, and that it has not experienced repeated freeze-thaw cycles or prolonged light exposure. Titrate the secondary if the working concentration has not been established.
- Signal varies between runs: Standardize sample preparation, reagent dilution, incubation, washing, and acquisition settings. Use fresh working dilutions where appropriate and record storage and handling history for each aliquot.
- Flow signal overlaps other channels: Review the fluorophore panel and compensation controls. If FITC cannot be resolved adequately in the instrument or panel, select a compatible secondary conjugate with a different fluorophore rather than trying to correct an unsuitable channel through staining changes alone.
- Microscopy signal fades during acquisition: Reduce unnecessary illumination and acquisition time, and use a mounting and imaging workflow suitable for fluorescent samples. FITC can be susceptible to photobleaching, so compare samples under controlled acquisition conditions.
Scope and Limitations
K1201 is a secondary reagent for mouse IgG detection; it does not identify the biological target independently of the primary antibody. Its polyclonal, affinity-purified character and FITC conjugation describe the reagent, not a guarantee of performance in every tissue, cell type, fixation method, or antibody pair. The dossier does not provide a working dilution, incubation time, tested species-reactivity panel, or application-specific performance data, so these parameters require local optimization.
Do not interpret brighter fluorescence alone as stronger target abundance or as proof of a pathway-level effect. Signal can also depend on primary-antibody binding, epitope accessibility, sample processing, secondary concentration, background, and acquisition settings. The product is not the right choice when the primary antibody is not mouse-derived, when a direct-labeling strategy is required, or when FITC spectral overlap or photobleaching is incompatible with the experiment. Confirm compatibility before applying the reagent to specialized live-cell or downstream workflows.
Conclusion
The FITC Goat Anti-Mouse IgG (H+L) Antibody offers a practical fluorescent readout for mouse IgG primary antibodies in immunofluorescence and flow cytometry. Use the stated concentration and storage conditions as product specifications, establish assay-specific working conditions by titration, and interpret fluorescence alongside appropriate controls. Careful handling, FITC-aware acquisition, and explicit validation of antibody compatibility make results easier to reproduce and assess.